Comparison between AU Small Finance Bank IPO and Eris Lifesciences IPO.
AU Small Finance Bank IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Eris Lifesciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of AU Small Finance Bank IPO is up to ₹1,912.51 Cr whereas the issue size of the Eris Lifesciences IPO is up to ₹1,740.49 Cr. The final issue price of AU Small Finance Bank IPO is ₹358.00 per share and of Eris Lifesciences IPO is ₹603.00 per share.
| AU Small Finance Bank IPO | Eris Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹355.00 per share | ₹600.00 per share |
| Issue Price (Upper) | ₹358.00 per share | ₹603.00 per share |
| Issue Price (Final) | ₹358.00 per share | ₹603.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹60.00 per share |
| Market Lot Size | 41 shares | 24 shares |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 5,34,22,169 shares | 2,88,75,000 shares |
| OFS Issue Size (Amount) | up to ₹1,912.51 Cr | up to ₹1,740.49 Cr |
| Issue Size Total | 5,34,22,169 shares | 2,88,75,000 shares |
| Issue Size Total (Amount) | up to ₹1,912.51 Cr | up to ₹1,740.49 Cr |
AU Small Finance Bank IPO opens on Jun 28, 2017, while Eris Lifesciences IPO opens on Jun 16, 2017. The closing date of AU Small Finance Bank IPO and Eris Lifesciences IPO is Jun 30, 2017, and Jun 20, 2017, respectively.
| AU Small Finance Bank IPO | Eris Lifesciences IPO | |
|---|---|---|
| Anchor Bid Date | Jun 27, 2017 | Jun 15, 2017 |
| Issue Open | Jun 28, 2017 | Jun 16, 2017 |
| Issue Close | Jun 30, 2017 | Jun 20, 2017 |
| Basis Of Allotment (Tentative) | Jul 05, 2017 | Jun 23, 2017 |
| Initiation of Refunds (Tentative) | Jul 06, 2017 | Jun 27, 2017 |
| Credit of Share (Tentative) | Jul 07, 2017 | Jun 28, 2017 |
| Listing date (Tentative) | Jul 10, 2017 | Jun 29, 2017 |
| Anchor Lockin End date 1 | Aug 04, 2017 | Jul 23, 2017 |
| Anchor Lockin End date 2 | Oct 03, 2017 | Sep 21, 2017 |
AU Small Finance Bank IPO P/E ratio is , as compared to Eris Lifesciences IPO P/E ratio of .
| AU Small Finance Bank IPO | Eris Lifesciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 36.03 | |||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹10176.18 Cr. | ₹8291.25 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the AU Small Finance Bank IPO Retail Individual Investors (RII) are offered 1,83,47,760 shares while in Eris Lifesciences IPO retail investors are offered 1,83,47,760 shares. Qualified Institutional Buyers (QIB) are offered 1,04,84,434 shares in AU Small Finance Bank IPO and 86,17,500 shares in Eris Lifesciences IPO.
| AU Small Finance Bank IPO | Eris Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,57,26,649 shares | 1,29,26,250 shares |
| Market Maker Reservation | ||
| QIB | 1,04,84,434 shares | 86,17,500 shares |
| NII | 78,63,326 shares | 43,08,750 shares |
| RII | 1,83,47,760 shares | 28,72,500 shares |
| Employee | 10,00,000 shares | 1,50,000 shares |
| Others | ||
| Total | 5,34,22,169 shares | 2,88,75,000 shares |
AU Small Finance Bank IPO subscribed 53.60x in total, whereas Eris Lifesciences IPO subscribed 3.29x.
| AU Small Finance Bank IPO | Eris Lifesciences IPO | |
|---|---|---|
| QIB (times) | 78.77x | 4.68x |
| NII (times) | 143.51x | 0.45x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.52x | 3.51x |
| Employee (times) | 1.45x | 0.86x |
| Other (times) | ||
| Total (times) | 53.60x | 3.29x |
